A Pilot Study Comparing the Safety and Efficacy of Everolimus With Other Medicines in Recipients of ECD/DCD Kidneys
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Everolimus
Related studies linked through entity extraction aliases.
Phase 1 TheraSphere + Everolimus With Neuroendocrine Tumors (NETs) + Liver Only or Liver Dominant Disease
- Status
- WITHDRAWN
- Phase
- PHASE1
Safety and Efficacy of AEB071 and EVEROLIMUS in Patients With CD79-mutant or ABC Subtype Diffuse Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
12 Month Athena Study: Everolimus vs. Standard Regimen in de Novo Kidney Transplant Patients
- Status
- COMPLETED
- Phase
- PHASE3
MPACT Study to Compare Effects of Targeted Drugs on Tumor Gene Variations
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study of Adding Everolimus to Adjuvant Hormone Therapy in Women With High Risk of Relapse, ER+ and HER2- Primary Breast Cancer, Free of Disease After Receiving at Least One Year of Adjuvant Hormone Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Phase II Open Label, Non-randomized Study of Sorafenib and Everolimus in Relapsed and Non-resectable Osteosarcoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AI
- Status
- COMPLETED
- Phase
- PHASE2
A Study Comparing AZD2014 vs Everolimus in Patients With Metastatic Renal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy Study of Sunitinib and Everolimus (Rotational vs Sequential Arm) in Pats. With m Clear Cell Renal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Everolimus for Treating Patients With Pancreatic Neuroendocrine Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Phase 1b/2 Trial Using Lapatinib, Everolimus and Capecitabine for Treatment of HER-2 Positive Breast Cancer With CNS Metastasis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase II Study of Everolimus in Combination With Exemestane Versus Everolimus Alone Versus Capecitabine in Advance Breast Cancer.
- Status
- COMPLETED
- Phase
- PHASE2
Pharmacokinetic of Everolimus and Atorvastatin Co-administration
- Status
- COMPLETED
- Phase
- NA
Everolimus Beyond Progress for Patients Who Had Progress Under Everolimus and Exemestane
- Status
- TERMINATED
- Phase
- PHASE3
PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy of RAD001/Everolimus in Autism and NeuroPsychological Deficits in Children With Tuberous Sclerosis Complex
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Biomarkers Before and After Nephrectomy of Locally Advanced or Metastatic Renal Cell Carcinoma Treated With Everolimus
- Status
- COMPLETED
- Phase
- PHASE2